Cure8 research brief
Distinguishing colorectal cancer from IBD-related inflammatory thickening can be challenging but crucial for treatment decisions. If validated, DECT parameters could offer a noninvasive tool to improve diagnostic accuracy when endoscopy is not possible.
Gastroenterologists, radiologists, clinicians evaluating colorectal wall thickening, researchers in imaging diagnostics, and patients who cannot undergo colonoscopy.
This abstract reports a retrospective study comparing dual-energy CT (DECT) multi-parameter measurements between colorectal cancer (CRC) and inflammatory bowel disease (IBD)-related colorectal wall thickening.
The authors measured iodine concentration (IC), normalized IC (NIC), effective atomic number (Zeff), DEI, CT attenuation at different keV, and the spectral slope, then used logistic regression and ROC analysis to identify predictors and build a combined diagnostic model.
Their combined DECT model (venous- and arterial-phase parameters) had the highest reported diagnostic accuracy (AUC 0.937) and they found venous-phase NIC to be the best single parameter.
The abstract concludes DECT multi-parametric analysis may help noninvasively distinguish CRC from IBD-related inflammatory thickening and could reduce the need for colonoscopy in some situations. This summary is grounded in the study abstract provided on PubMed and does not represent a full review of the complete article.
This is a retrospective single-center study based on the abstract. Results are promising but require external validation, prospective testing, and assessment of real-world clinical impact before changing practice.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Better triage methods that combine FIT with demographics and blood biomarkers could reduce unnecessary colonoscopies while keeping sensitivity for colorectal cancer and other serious findings, which matters for...
This study highlights factors—tumor location, age, smoking, and having IBD—that were associated with survival and progression in a Lebanese CRC cohort.
This study helps distinguish patterns of colorectal dysplasia seen in people without IBD from those seen in IBD, which may affect how pathologists and clinicians interpret biopsy findings and consider cancer risk and...
